Semen Analysis

Total Page:16

File Type:pdf, Size:1020Kb

Semen Analysis 3 Semen Analysis Meaghanne K. Caraballo, Alyssa M. Giroski, Rakesh Sharma, and Ashok Agarwal Introduction Semen Collection Conceiving a child is often one of the most desired goals in a Semen samples should ideally be collected after abstaining from couple’s relationship, but unfortunately this cannot be achieved ejaculation for a minimum of 2 days but not more than 1 week [3]. naturally in all cases. Infertility is a couple problem that affects Longer abstinence times can result in hyperspermia or a semen 15%–20% of the population. Of these, 30%–40% can be attrib- volume greater than 5 mL. When the patient is instructed to uted to male-factor infertility, and 30%–40% can be attributed to provide a semen sample, they should be given the appropriate female-factor infertility. In the remaining 20%, there is a com- instructions to ensure that the semen sample is collected prop- bination of both male and female factors [1,2]. To assess male erly and free of contaminants that may affect semen quality [4]. factor infertility, semen analysis is the primary test that a physi- It is recommended that semen samples be collected via masturba- cian will order. A formal laboratory evaluation of semen analysis tion only into a sterile, wide-mouthed plastic container. Samples requires adherence to strict guidelines according to the World collected via coitus interruptus should not be accepted because Health Organization (WHO) guidelines [3]. they will be contaminated with cellular debris and bacteria. One Evaluation of semen is performed using standardized refer- of the major concerns with this method of collection is that the ence ranges (Table 3.1) established by WHO in 2010 [3]. Routine rst portion of ejaculate, which usually contains the highest con- semen analysis includes macroscopic evaluation, including color, centration of spermatozoa, is lost. Additionally, the acidic pH of volume, pH, viscosity, and liquefaction. Microscopic evaluation, the vaginal uid can adversely affect sperm motility. In special includes round cell count, concentration, total motility includ- cases, patients may use a specialized collection condom, such ing progressive motility retrograde semen analysis, sperm mor- as a MaleFactor-Pak. These types of condoms are made of inert phology, sperm viability; and sperm-function testing including polyurethane and do not contain spermicides and, therefore, fructose testing, hypo-osmotic swelling, and antibody testing. maintain semen motility. No lubricants or saliva should be used Advanced sperm testing is available in specialized andrology in the collection process because they may adversely affect the laboratories for evaluating oxidative stress (OS) and includes sample quality. Immediately after collection, semen samples measurement of reactive oxygen species (ROS), total antioxidant should undergo a standard liquefaction period. If the patient capacity (TAC), oxidation reduction potential (ORP) and sperm collects off site, the sample must be delivered to the laboratory DNA fragmentation (SDF). within 1 hour of collection. It must be kept at body temperature to protect against temperature uctuations. After 60 minutes, sperm motility may be compromised [2] and, thus, it is recommended that the analysis be performed as soon as possible after liquefac- tion has occurred. TABLE 3.1 Normal Values (fth percentile) for Semen Analysis According to WHO 2010 Guidelines Macroscopic Evaluation of Semen Parameter References The macroscopic evaluation of semen includes semen volume, Volume (mL) 1.5 pH, viscosity, liquefaction, and age of the sample. pH Sperm concentration (×106/mL) 15 Motility (% total) 40 Appearance Morphology ( normal) 4 % After liquefaction, semen samples undergo a macroscopic Vitality ( ) 58 % analysis. Normal semen sample is opaque in appearance White blood cells ( 106/ml) 1.0 106 × < × and homogenous. If the specimen has a clear appearance, 19 20 Male Infertility in Reproductive Medicine the patient’s sperm concentration may be too low or possi- bly even azoospermic. On the other hand, if it has a reddish- Microscopic Evaluation of Semen brown appearance, then there may be red blood cells present. Hematospermia (i.e., appearance of blood in the semen) can be Round Cells attributed to a variety of factors such as infection or inam - Round cells in the semen sample consist of immature germ cells mation in any area of the male reproductive system, excessive and leukocytes. The presence of excessive immature germ cells masturbation, obstruction, tumors, or polyps. Certain phar- in the ejaculate may indicate an environment of oxidative stress maceutical drugs and medical conditions (e.g., jaundice or (OS) during spermatogenesis [6]. Therefore, it is important to dif- prostate infection) can cause an abnormal appearance of the ferentiate between these two round cells. To distinguish between semen. Urine contamination can alter the appearance of semen the two, round cells are counted in a high-power eld. Presence to a yellowish color. of more than 5 round cells or >1 × 106 round cells on the wet prep indicates testing for presence of white blood cells accord- 6 Semen Volume ing to WHO guidelines. Presence of <1.0 × 10 round cells may contain activated leukocytes, which can produce the ROS that are The volume of the ejaculate is largely comprised of the secre - harmful for the spermatozoa [7,8]. tions of the accessory glands such as the seminal vesicles and the prostate gland. A small portion of the volume also comes Leukocytospermia from the bulbourethral glands and the epididymis. The stan- Quantication of leukocytes in semen is performed on a wet prep dard volume for the ejaculate is ≥1.5 mL by WHO reference range [3]. and is tested by the myeloperoxidase or Endtz Test [9]. This test iden- When a semen sample measures less than 0.5 mL it is ties the peroxidase positive granulocytes that stain dark brown: referred to as hypospermia. This abnormality can be the result i.e. macrophages and neutrophils. Presence of >1 × 106 wbc/mL of many different underlying factors such as hypogonadism, ret- of the sample is indicative of leukocytospermia [3]. rograde ejaculation, and obstruction of the lower urinary tract or a congenital bilateral absence of the vas deferens. It is also Concentration and Motility important to note that the rst couple of drops of ejaculate typi- The concentration of a semen analysis is calculated by the cally have a high sperm concentration. Any incomplete sample number of spermatozoa in 1 mL of semen. The reference or split ejaculates must be reported by the patient and should 6 value is ≥15 × 10 /mL. The total sperm number or count is be documented in the analysis report. An incomplete sample the total number of spermatozoa in the entire semen ejaculate. can account for reduced semen volumes. Some patients do Oligozoospermia and azoospermia are diagnosed by the total not produce an ejaculate after orgasm and instead produce dry number of sperm count. Oligozoospermia is dened as sperm ejaculate. This is more commonly referred to as aspermia. An 6 concentration <15 × 10 /mL. Azoospermia or cryptozoospermia accurate record of semen volume is essential. The laboratory is referred to as the absence of spermatozoa in the ejaculate. may use a graduated serological pipette, a graduated 15 mL Calculating the concentration of semen is done by properly conical centrifuge tube or weight for accuracy. The WHO rec- mixing the semen through pipetting or vortexing the ejaculate. ommends using a preweighed sterile collection container for the The sample is placed on a xed counting chamber. A minimum most accurate volume [3]. of 200 spermatozoa are observed under 20×. A minimum of 200 spermatozoa should be counted as suggested by WHO; a 10 × 10 Semen Viscosity grid is placed in the eye piece for counting the sperm using a phase contrast microscope and 20× objective (Figure 3.1). It is comprised Semen viscosity measures the seminal uid’s resistance to ow. of a total of 100 squares in 10 rows and 10 columns. A row factor is High viscosity is determined by the elastic property of the semen applied to obtain the concentration as shown in Table 3.2. sample when it is free dropped from a pipette. A thread length greater than 2 cm is considered abnormally viscous. High viscos- TC = Total number of sperm counted ity after complete liquefaction can affect motility, concentration, F = Total number of elds and antibody-coated spermatozoa. In cases of moderate or severe RF = Row factor viscosity, a preweighed vial of trypsin powder (5 mg) can be used MF = Microscope factor to break the viscosity. S = Number of squares on a grid Concentration = (TC/F) × RF × MF/S Semen pH TABLE 3.2 The semen sample is primarily made up of the alkaline uid from the seminal vesicles and the acidic uid from the pros - Calculating the Concentration tate. The pH of the two uids combined should be in the range Number of Rows Counted Row Factor of 7.2–8.2. A pH of <7.0 in a semen sample may indicate an obstruction in the ejaculatory duct [5]. This results in an 1 10 absence of alkaline secretions from the seminal vesicle uid. 2 5 5 2 A higher pH could indicate the presence of an underlying 10 1 infection [5]. Semen Analysis 21 40X FIGURE 3.1 Measurement of sperm concentration and motility by a xed counting chamber and a phase contrast microscope. Example: TABLE 3.3 Calculating Forward Progression Concentration = (167/5) × 5 × (20/100) = 33.40 × 106/mL Grade Letter Total sperm count of the sample is calculated by multiplying the 1 D total volume by the concentration of the sample. 2 C 3 B Example: 4 A Concentration = 33.40 × 106/mL AB ++ C Percentage forward progression = ×100 Volume of the sample = 2.0 mL AB ++ CD + Total sperm count = 33.40 × 106/mL × 2.0 mL = 66.80 106 × Computer-Assisted Semen Analysis Computer-assisted sperm analysis (CASA) is an alternative Motility and Forward Progression method to the manual semen analysis.
Recommended publications
  • The Male Reproductive System
    Management of Men’s Reproductive 3 Health Problems Men’s Reproductive Health Curriculum Management of Men’s Reproductive 3 Health Problems © 2003 EngenderHealth. All rights reserved. 440 Ninth Avenue New York, NY 10001 U.S.A. Telephone: 212-561-8000 Fax: 212-561-8067 e-mail: [email protected] www.engenderhealth.org This publication was made possible, in part, through support provided by the Office of Population, U.S. Agency for International Development (USAID), under the terms of cooperative agreement HRN-A-00-98-00042-00. The opinions expressed herein are those of the publisher and do not necessarily reflect the views of USAID. Cover design: Virginia Taddoni ISBN 1-885063-45-8 Printed in the United States of America. Printed on recycled paper. Library of Congress Cataloging-in-Publication Data Men’s reproductive health curriculum : management of men’s reproductive health problems. p. ; cm. Companion v. to: Introduction to men’s reproductive health services, and: Counseling and communicating with men. Includes bibliographical references. ISBN 1-885063-45-8 1. Andrology. 2. Human reproduction. 3. Generative organs, Male--Diseases--Treatment. I. EngenderHealth (Firm) II. Counseling and communicating with men. III. Title: Introduction to men’s reproductive health services. [DNLM: 1. Genital Diseases, Male. 2. Physical Examination--methods. 3. Reproductive Health Services. WJ 700 M5483 2003] QP253.M465 2003 616.6’5--dc22 2003063056 Contents Acknowledgments v Introduction vii 1 Disorders of the Male Reproductive System 1.1 The Male
    [Show full text]
  • Clinical and Therapeutic Management of Male Infertility in Thies, Senegal
    Open Journal of Urology, 2019, 9, 1-10 http://www.scirp.org/journal/oju ISSN Online: 2160-5629 ISSN Print: 2160-5440 Clinical and Therapeutic Management of Male Infertility in Thies, Senegal Yoro Diallo, Modou Diop N’diaye, Saint Charles Kouka, Mama Sy Diallo, Mehdi Daher, Amy Diamé, Modou Faye, Néné Mariama Sow, Ramatoulaye Ly, Cheikh Diop, Seydou Diaw, Cheickna Sylla Department of Urology, Faculty of Health Sciences, University of Thies, Thies, Senegal How to cite this paper: Diallo, Y., N’diaye, Abstract M.D., Kouka, S.C., Diallo, M.S., Daher, M., Diamé, A., Faye, M., Sow, N.M., Ly, R., Objective: To evaluate the clinical and therapeutic aspects of male subfertility Diop, C., Diaw, S. and Sylla, C. (2019) in the Region of Thies. Patients and methods: This is a retrospective and Clinical and Therapeutic Management of analytical study involving patients followed for subfertility over a period of 4 Male Infertility in Thies, Senegal. Open Journal of Urology, 9, 1-10. years from January 2013 to November 2017 at the level of 3 health structures https://doi.org/10.4236/oju.2019.91001 in the region of Thies. Results: During the period, we collected 201 patients. The average age was 38 ± 8.4 years with a greater distribution in the age Received: November 5, 2018 Accepted: January 11, 2019 group 30-39 years. Primary subfertility was predominant with 81.1% of cases. Published: January 14, 2019 The average duration was 5 years. We found a history of urethritis (4%) and orchiepididymitis (2.5%). Thirty-three percent of patients presented a vari- Copyright © 2019 by author(s) and cocele (67 cases).
    [Show full text]
  • 1997 Asa Program.Pdf
    Friday, February 21 12:00 NOON- 11:00 PM Executive Council Meeting (lunch and supper served) (Chesapeake Room NB) Saturday, February 22 8:00-9:40 AM Postgraduate Course (Constellation 3:00-5:00 PM Postgraduate Course (Constellation Ballroom A) Ballroom A) 9:40-1 0:00 AM Refreshment Break 6:00-7:00 PM Student Mixer (Maryland Suites-Balti­ 10:00-12:00 NOON Postgraduate Course (Constellation more Room) Ballroom A) 7:00-9:00 PM ASA Welcoming Reception (Atrium 12:00-1 :00 PM Lunch (on your own) Lobby) 7:00-9:00 PM Exhibits Open (Constellation Ball­ I :00-2:40 PM Postgraduate Course (Constellation Ballroom A) rooms E, F) 2:40-3:00 PM Refreshment Break 9:00- 1 I :00 PM Executive Council Meeting (Chesa­ peake Room NB) Sunday, February 23 7:45-8:00 AM Welcome and Opening Remarks 12:00-1 :30 PM Women in Andrology Luncheon (Ches­ (Constellation Ballroom A) apeake Room NB) 8:00-9:00 AM Serono Lecture: "Genetics of Prostate Business Meeting 12:00-12:30 Cancer" Patrick Walsh (Constellation Speaker and Lunch 12:30-1:30 Ballroom A) I :30-3:00 PM Symposium I: "Regulation of Testicu­ 9:00-10:00 AM American Urological Association Lec­ lar Growth and Function" (Constellation ture: "New Medical Treatments of Im­ Ballroom A) potence" Irwin Goldstein (Constella­ Patricia Morris tion Ballroom A) Martin Matzuk 10:00-10:30 AM Refreshment Break/Exhibits 3:00-3:30 PM Refreshment Break/Exhibits (Constellation Ballrooms E, F) (Constellation Ballrooms E, F) 10:30-12:00 NOON Oral Session I: "Genes and Male Repro­ 3:30-4:30 PM Oral Session II: "Calcium Channels duction" (Constellation Ballroom A) and Male Reproduction" (Constellation Ballroom A) 12:00- 1 :30 PM Lune (on your own) � 4:30-6:30 PM Poster Session I (Constellation Ball­ �4·< rooms C, D) \v\wr 7:30-11:00 PM Banquet (National Aquarium) Monday, February 24 7:00-8:00 AM Past Presidents' Breakfast 12:00-1 :30 PM Simultaneous Events: (Pratt/Calvert Rooms) I.
    [Show full text]
  • Let's Talk About What's Hard
    Let’s Talk About What’s Hard “Bobby” Duc Tran, MD, MSc Assistant Professor, Emory University 2017 HoG State Meeting Case Presentation March 3, 2017 WARNING The following presentation contains some foul language, nudity, and images that some viewers may find upsetting Case Presentation • 32yo white male • Past medical history: • severe hemophilia B • hemophilic arthropathy of bilateral knees and elbows • Marfan’s syndrome • atrial fibrillation • blind in one eye • hepatitis C • Current hemophilia treatment: Aprolix • Previous issues with mixing the factor. Case Presentation • Past surgeries: • Aortic root repair • Full dentition extraction • Bilateral knee arthroscopic synevectomies at 5 and 7 yo • Left orchiectomy for testicular torsion • Last seen in clinic for his annual comprehensive visit in 9/2016 Case Presentation • Called to the HTC clinic nurse on 12/5/2016 • Embarrassingly he reported: • This morning “my penis and testicles are blackish purple and feels like a bleed” • I had sex with my wife last night • Last infused 3 days ago and is not due for next infusion until tomorrow • “This has never happened before” How to talk about this? • Approach from a professional standpoint • Discuss these topics when discussing safe sexual practices • Gauge the patient’s comfort with using medical terms • Nicknames used: • Dick, dong, schlong, wiener, peen, so many more • Not wenis What to do first? • When was the bleeding recognized? • Did you hear/feel a “pop”? • Recognize associated injuries • Urethra, bladder, vascular • Consider GU referral
    [Show full text]
  • Chronic Bacterial Prostatitis Treated with Phage Therapy After Multiple Failed Antibiotic Treatments
    CASE REPORT published: 10 June 2021 doi: 10.3389/fphar.2021.692614 Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments Apurva Virmani Johri 1*, Pranav Johri 1, Naomi Hoyle 2, Levan Pipia 2, Lia Nadareishvili 2 and Dea Nizharadze 2 1Vitalis Phage Therapy, New Delhi, India, 2Eliava Phage Therapy Center, Tbilisi, Georgia Background: Chronic Bacterial Prostatitis (CBP) is an inflammatory condition caused by a persistent bacterial infection of the prostate gland and its surrounding areas in the male pelvic region. It is most common in men under 50 years of age. It is a long-lasting and Edited by: ’ Mayank Gangwar, debilitating condition that severely deteriorates the patient s quality of life. Anatomical Banaras Hindu University, India limitations and antimicrobial resistance limit the effectiveness of antibiotic treatment of Reviewed by: CBP. Bacteriophage therapy is proposed as a promising alternative treatment of CBP and Gianpaolo Perletti, related infections. Bacteriophage therapy is the use of lytic bacterial viruses to treat University of Insubria, Italy Sandeep Kaur, bacterial infections. Many cases of CBP are complicated by infections caused by both Mehr Chand Mahajan DAV College for nosocomial and community acquired multidrug resistant bacteria. Frequently encountered Women Chandigarh, India Tamta Tkhilaishvili, strains include Vancomycin resistant Enterococci, Extended Spectrum Beta Lactam German Heart Center Berlin, Germany resistant Escherichia coli, other gram-positive organisms such as Staphylococcus and Pooria Gill, Streptococcus, Enterobacteriaceae such as Klebsiella and Proteus, and Pseudomonas Mazandaran University of Medical Sciences, Iran aeruginosa, among others. *Correspondence: Case Presentation: We present a patient with the typical manifestations of CBP.
    [Show full text]
  • Diagnosis and Management of Infertility Due to Ejaculatory Duct Obstruction: Summary Evidence ______
    Vol. 47 (4): 868-881, July - August, 2021 doi: 10.1590/S1677-5538.IBJU.2020.0536 EXPERT OPINION Diagnosis and management of infertility due to ejaculatory duct obstruction: summary evidence _______________________________________________ Arnold Peter Paul Achermann 1, 2, 3, Sandro C. Esteves 1, 2 1 Departmento de Cirurgia (Disciplina de Urologia), Universidade Estadual de Campinas - UNICAMP, Campinas, SP, Brasil; 2 ANDROFERT, Clínica de Andrologia e Reprodução Humana, Centro de Referência para Reprodução Masculina, Campinas, SP, Brasil; 3 Urocore - Centro de Urologia e Fisioterapia Pélvica, Londrina, PR, Brasil INTRODUCTION tion or perineal pain exacerbated by ejaculation and hematospermia (3). These observations highlight the Infertility, defined as the failure to conceive variability in clinical presentations, thus making a after one year of unprotected regular sexual inter- comprehensive workup paramount. course, affects approximately 15% of couples worl- EDO is of particular interest for reproduc- dwide (1). In about 50% of these couples, the male tive urologists as it is a potentially correctable factor, alone or combined with a female factor, is cause of male infertility. Spermatogenesis is well- contributory to the problem (2). Among the several -preserved in men with EDO owing to its obstruc- male infertility conditions, ejaculatory duct obstruc- tive nature, thus making it appealing to relieve the tion (EDO) stands as an uncommon causative factor. obstruction and allow these men the opportunity However, the correct diagnosis and treatment may to impregnate their partners naturally. This review help the affected men to impregnate their partners aims to update practicing urologists on the current naturally due to its treatable nature. methods for diagnosis and management of EDO.
    [Show full text]
  • Hypospermia Improvement in Dogs Fed on a Nutraceutical Diet
    Hindawi e Scientific World Journal Volume 2018, Article ID 9520204, 4 pages https://doi.org/10.1155/2018/9520204 Research Article Hypospermia Improvement in Dogs Fed on a Nutraceutical Diet Francesco Ciribé,1 Riccardo Panzarella,2 Maria Carmela Pisu,3 Alessandro Di Cerbo ,4,5 Gianandrea Guidetti,6 and Sergio Canello7 1 Ambulatorio Veterinario CittadiFermo,ViaFalconesnc,Fermo,Italy` 2Ospedale Veterinario Himera, Via Antonio de Saliba 2, Palermo, Italy 3Centro di Referenza Veterinario, Corso Francia 19, Torino, Italy 4Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy 5Department of Medical, Oral, and Biotechnological Sciences, Dental School, University G. d’Annunzio of Chieti-Pescara, Chieti, Italy 6Sanypet Spa, Research and Development Department, Bagnoli di Sopra, Padova, Italy 7Research and Development Department, Forza10 USA Corp., Orlando, FL, USA Correspondence should be addressed to Alessandro Di Cerbo; [email protected] Received 6 June 2018; Accepted 16 October 2018; Published 1 November 2018 Academic Editor: Juei-Tang Cheng Copyright © 2018 Francesco Cirib´e et al. Tisis an open accessarticle distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Male dog infertility may represent a serious concern in the canine breeding market. Te aim of this clinical evaluation was to test the efcacy of a commercially available nutraceutical diet, enriched with Lepidium meyenii, Tribulus terrestris, L-carnitine, zinc, omega-3 (N-3) fatty acids, beta-carotene, vitamin E, and folic acid, in 28 male dogs sufering from infertility associated with hypospermia. All dogs received the diet over a period of 100 days.
    [Show full text]
  • Hemospermia: Long-Term Outcome in 165 Patients
    International Journal of Impotence Research (2013) 26, 83–86 & 2013 Macmillan Publishers Limited All rights reserved 0955-9930/13 www.nature.com/ijir ORIGINAL ARTICLE Hemospermia: long-term outcome in 165 patients J Zargooshi, S Nourizad, S Vaziri, MR Nikbakht, A Almasi, K Ghadiri, S Bidhendi, H Khazaie, H Motaee, S Malek-Khosravi, N Farshchian, M Rezaei, Z Rahimi, R Khalili, L Yazdaani, K Najafinia and M Hatam Long-term course of hemospermia has not been addressed in the sexual medicine literature. We report our 15 years’ experience. From 1997 to 2012, 165 patients presented with hemospermia. Mean age was 38 years. Mean follow-up was 83 months. Laboratory evaluation and testis and transabdominal ultrasonography was done in all. Since 2008, all sonographies were done by the first author. One patient had urinary tuberculosis, one had bladder tumor and three had benign lesions at verumontanum. One patient had bilateral partial ejaculatory duct obstruction by stones. All six patients had persistent, frequently recurring or high-volume hemospermia. All pathologies were found in young patients. In the remaining 159 patients (96%), empiric treatment was given with a fluoroquinolone (Ciprofloxacin) plus an nonsteroidal anti-inflammatory drug (Celecoxib). In our 15 years of follow-up, no patient later developed life-threatening disease. Diagnostic evaluation of hemospermia is not worthwhile in the absolute majority of cases. Advanced age makes no difference. Only high-risk patients need to be evaluated. The vast majority of cases may be safely and
    [Show full text]
  • Occupational Exposure Associated with Reproductive Dysfunction
    Journal of J Occup Health 2004; 46: 1–19 Occupational Health Review Occupational Exposure Associated with Reproductive Dysfunction Sunil KUMAR Reproductive Toxicology and Histochemistry Division, National Institute of Occupational Health, India Abstract: Occupational Exposure Associated with as a very sensitive reproduction issue is involved with Reproductive Dysfunction: Sunil KUMAR. exposure to these chemicals. Occupational exposures Reproductive Toxicology and Histochemistry often are higher than environmental exposures, so that Division, National Institute of Occupational Health, epidemiological studies should be conducted on these India—Evidence suggestive of harmful effects of chemicals, on a priority basis, which are reported to occupational exposure on the reproductive system and have adverse effects on reproduction in the related outcomes has gradually accumulated in recent experimental system. decades, and is further compounded by persistent (J Occup Health 2004; 46: 1–19) environmental endocrine disruptive chemicals. These chemicals have been found to interfere with the function Key words: Occupational exposure, Reproductive of the endocrine system, which is responsible for dysfunction, Male reproduction, Female reproduction, growth, sexual development and many other essential Persistent chemicals, Toxic fumes, Solvents, physiological functions. A number of occupations are Pesticides, Metals, Endocrine disruptors being reported to be associated with reproductive dysfunction in males as well as in females. Generally, Human beings
    [Show full text]
  • Effects of Methanolic Extract of Citrullus Lanatus Seed on Experimentally Induced Prostatic Hyperplasia
    European Journal of Medicinal Plants 1(4): 171-179, 2011 SCIENCEDOMAIN international www.sciencedomain.org Effects of Methanolic Extract of Citrullus lanatus Seed on Experimentally Induced Prostatic Hyperplasia Adesanya A. Olamide 1*, Olaseinde O. Olayemi 1, Oguntayo O. Demetrius 1, Otulana J. Olatoye 1 and Adefule A. Kehinde 1 1Department of Anatomy, Faculty of Basic Medical Sciences, Olabisi Onabanjo University, Ikenne Campus, Ogun State, Nigeria. Received 22nd June 2011 th Research Article Accepted 18 July 2011 Online Ready 4th October 2011 ABSTRACT Aims: To investigate the effects of methanolic extract of Citrullus lanatus seed (MECLS) on experimentally induced benign prostate hyperplasia. Study design: Animal model of experimentally induced prostatic hyperplasia. Place and Duration of Study: Department of Anatomy, Faculty of Basic Medical Sciences, Ikenne Campus, Ikenne, Ogun State, Nigeria, between May 2010 and August 2010. Methodology: Twenty adult male Wistar rats weighing about 135-180g were randomly divided into four groups of five animals each. Group I, Normal control (NC) was given corn oil as placebo 1g/Kg BW ; Group II, Hormone treated control (HTC), Groups III, and IV hormone and extract treated (HTEC), received continuous dosage of 300µg and 80µg of testosterone (T) and estradiol (E 2) respectively on alternate days for three weeks subcutaneously in the inguinal region while the extract treated received an additional 2g/Kg BW (low dose) and 4g/Kg BW (high dose) of extract orally for 4 weeks after the successful induction of prostate enlargement. Immediately after induction some animals were randomly selected and sacrificed for gross inspection of prostate enlargement and sperm count evaluation, these procedures were repeated again after four weeks of extract treatment.
    [Show full text]
  • Jon Rees, Mark Abrahams, Victor Abu, Trevor Allan, Andrew Doble, Theresa Neale, Penny Nixon, Maxwell Saxty, Sarah Mee, Alison Co
    Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. Sept 2014 Jon Rees,1 Mark Abrahams,2 Victor Abu,3 Trevor Allan,4 Andrew Doble,5 Theresa Neale,6 Penny Nixon,7 Maxwell Saxty,8 Sarah Mee,9 Alison Cooper,10 Kirsty Haves,11 and Jenny Lee12 1GP (Chair of Prostatitis Expert Reference Group), Backwell and Nailsea Medical Group, Bristol; 2Pain Consultant, Addenbrooke’s Hospital, Cambridge; 3Clinical Nurse Specialist – Prostate, University College London Hospitals, London; 4Patient Representative; 5Consultant Urologist, Addenbrooke’s Hospital, Cambridge; 6Urology Clinical Nurse Specialist, South Warwickshire Foundation Trust; 7Physiotherapist Specialist, Addenbrooke’s Hospital, Cambridge; 8Cognitive Behavioural Therapist, Addenbrooke’s Hospital, Cambridge; 9Policy and Evidence Manager, Prostate Cancer UK; 10Senior Research Analyst, Prostate Cancer UK; 11Senior Account Manager, Hayward Medical Communications; 12Project Manager, Hayward Medical Communications A quick reference guide version of this guideline can be downloaded from: www.prostatecanceruk.org/prostatitisguideline ENDORSED BY September 2014 1 (due for review September 2017) Page Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). A company limited by guarantee registered number 2653887 (England and Wales). Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. Sept 2014 Introduction
    [Show full text]
  • Reduced Prostaglandin Levels in the Semen of Men with Very High Sperm Concentrations R
    Reduced prostaglandin levels in the semen of men with very high sperm concentrations R. W. Kelly, I. Cooper and A. A. Templeton Medical Research Council, Unit ofReproductive Biology, 2 Forrest Road, Edinburgh EHI 2QW, and *Department of Obstetrics and Gynaecology, University of Edinburgh, 23 Chalmers Street, Edinburgh EH3 9ER, U.K. Summary. The prostaglandin levels have been measured in a group of men with sperm concentrations greater than 300 \m=x\106/ml and compared with the levels in men with sperm concentrations of 50 to 150 \m=x\106/ml. The distribution of the PG levels in all groups was highly skewed but the data could be transformed to a normal distribution by taking logarithms. Comparison of the PG levels showed a highly significant lowering of the PG levels in the polyzoospermic group when compared with either of the groups with normal sperm concentrations. Introduction Although prostaglandins (PGs) were first discovered in human seminal plasma (Goldblatt, 1933; von Euler, 1934, 1935) and although a relationship between PG levels in semen and fertility were apparently established in early investigations of seminal PG content (Bygdeman, Fredricsson, Svanborg & Samuelsson, 1970), the function of these compounds in semen is still not clear. The first PGs to be found in human semen were those of the E and F series (Samuelsson, 1963) which were followed by reports of the A, B, 19-hydroxy A and 19-hydroxy series (Hamberg & Samuelsson, 1966).The finding that the 19-hydroxy PGEs are the major PGs of human semen (Taylor & Kelly, 1974; Jonsson, Middleditch & Desiderio, 1975) has led to the suggestion that the A, B, 19-hydroxy A and 19-hydroxy PGs in semen and elsewhere are artefacts (Middleditch, 1975).
    [Show full text]